This Article Free upon publication Full Text Full Text (PDF) Data Supplement All Versions of this Article: 2/4/278    most recent CIRCHEARTFAILURE.108.807826v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Shah, S. J. Articles by Gomberg-Maitland, M. Search for Related Content PubMed PubMed Citation Articles by Shah, S. J. Articles by Gomberg-Maitland, M. Related Collections Exercise testing Pulmonary circulation and disease Epidemiology

Original Articles

Value of Exercise Treadmill Testing in the Risk Stratification of Patients With Pulmonary Hypertension

Sanjiv J. Shah, MD; Thenappan Thenappan, MD; Stuart Rich, MD; James Sur, MD; Stephen L. Archer, MD and Mardi Gomberg-Maitland, MD, MSc

From the Division of Cardiology (S.J.S.), Department of Medicine, Northwestern University Feinberg School of Medicine; and the Section of Cardiology (T.T., S.R., J.S., S.L.A., M.G.), Department of Medicine, University of Chicago, Chicago, Ill.

Correspondence to Mardi Gomberg-Maitland, MD, MSc, Director of Pulmonary Hypertension, University of Chicago Medical Center, 5841 S Maryland Ave, MC 2016, Chicago, IL 60637. E-mail mgomberg{at}medicine.bsd.uchicago.edu

Received July 16, 2008; accepted March 30, 2009.

Background— The ability of the Naughton-Balke exercise treadmill test, an objective indicator of exercise capacity, to predict abnormal hemodynamics and mortality in pulmonary hypertension is unknown.

Methods and Results— We performed a cohort study of 603 patients with pulmonary hypertension from 1982 to 2006, and studied the utility of exercise treadmill test as a predictor of abnormal hemodynamics and death. We used multivariable linear regression to determine whether exercise capacity, measured in metabolic equivalents, was associated with abnormal hemodynamics, and we used a Cox proportional hazards model to determine whether decreased exercise capacity predicted death. Mean age was 50±15 years, 76% were women, 63% had World Health Organization category I pulmonary arterial hypertension, and 23% were World Health Organization functional classes I and II. Mean exercise capacity was 3.7±2.2 metabolic equivalents. Decreased exercise capacity was independently associated with elevated right atrial and mean pulmonary artery pressure, decreased cardiac index, and increased pulmonary vascular resistance. During median follow-up of 4.6 years, 36% of the patients died. Decreased exercise capacity was associated with mortality (multivariable hazard ratio, 1.18; 95% CI, 1.01 to 1.37 for each 1-metabolic equivalent decrease in exercise capacity; P=0.031; P=0.052 after adjusting for invasive hemodynamic variables). Decreased exercise capacity also predicted mortality in functional classes I–II patients, 24% of whom died (hazard ratio, 1.53; 95% CI, 1.04 to 2.26 for each 1-metabolic equivalent decrease in exercise capacity; P=0.032), although this association did not persist after adjusting for invasive hemodynamic variables (P=0.63).

Conclusions— Reduced exercise capacity on exercise treadmill test is associated with worse hemodynamics and is a predictor of mortality in patients with pulmonary hypertension.

Key Words: pulmonary hypertension • exercise • hemodynamics • mortality

---

 

CLINICAL PERSPECTIVE